Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a version bump of the page or site rendering. There are no changes to the study details or substantive content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record now displays a Results Submitted status, signaling that results have been submitted to ClinicalTrials.gov and are awaiting posting, instead of No Results Posted.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.5.2 added. Revision: v3.5.0 removed.SummaryDifference0.0%

- Check53 days agoChange DetectedPublication entry added for the Nat Med 2026 article Benralizumab versus placebo for hypereosinophilic syndrome with the full author list. The entry is auto-filled from PubMed.SummaryDifference0.4%

- Check67 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.